✦ LIBER ✦

4 PROVE1: RESULTS FROM A PHASE 2 STUDY OF TELAPREVIR WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH HEPATITIS C

✍ Scribed by J.G. Mchutchison; G.T. Everson; S.C. Gordon; I. Jacobson; R. Kauffman; L. McNair; A. Muir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

223 Prove1: Results from a Phase 2 Study

✍ Everson, Gregory T.; Jacobson, Ira M.; Gordon, Stuart C.; McHutchison, John G.; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

160 Prove2 Study: Treatment of Chronic H

✍ Hezode, Christophe; Ferenci, Peter; Dusheiko, Geoffrey M.; Tran, Albert; Grange, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 96 KB

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FRO

✍ P. Kwo; E. Lawitz; J. McCone; E. Schiff; J. Vierling; D. Pound; M. Davis; J. Gal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

58 TREATMENT OF CHRONIC HEPATITIS C WITH

✍ G.M. Dusheiko; C. Hezode; S. Pol; T. Goeser; J.-P. Bronowicki; M. Bourliere; P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

50 ACTIVITY OF TELAPREVIR ALONE OR IN CO

✍ G.R. Foster; C. Hezode; J.-P. Bronowicki; G. Carosi; O. Weiland; L. Verlinden; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

57 ACTIVITY OF TELAPREVIR ALONE OR IN CO

✍ G.R. Foster; C. Hezode; J.-P. Bronowicki; G. Carosi; O. Weiland; L. Verlinden; R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB